J. Goldman & Co’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.1K Buy
+8,200
New +$33.6K ﹤0.01% 637
2024
Q3
Sell
-500,000
Closed -$3.67M 564
2024
Q2
$3.67M Sell
500,000
-2,312,500
-82% -$20.2M 0.1% 201
2024
Q1
$28.2M Sell
2,812,500
-1,124,800
-29% -$9.85M 0.91% 28
2023
Q4
$27.6M Buy
3,937,300
+3,062,300
+350% +$20.4M 1.12% 20
2023
Q3
$6.95M Buy
+875,000
New +$5.52M 0.24% 113
2022
Q3
Sell
-1,386,000
Closed -$14.3M 450
2022
Q2
$14.3M Buy
+1,386,000
New +$20.6M 0.7% 39
2021
Q4
Sell
-437,300
Closed -$13.8M 404
2021
Q3
$13.8M Buy
+437,300
New +$15.2M 0.69% 30
2021
Q2
Sell
-480,000
Closed -$20.4M 472
2021
Q1
$20.4M Buy
+480,000
New +$22.1M 0.65% 36

Other funds holding MSOS

J. Goldman & Co's MSOS Position: Q3 2024 in Review

J. Goldman & Co sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2024, closing a stake of 96,251 shares — an estimated $706K sold.

J. Goldman & Co first reported a position in MSOS in Q4 2021 and held it in 7 quarters. The position peaked at $4.64M in Q1 2024. 170 funds tracked by Wall St. Rank hold MSOS as of Q3 2024.

  • J. Goldman & Co reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2024 after selling out during the quarter.
  • J. Goldman & Co sold 96,251 AdvisorShares Pure US Cannabis ETF shares in Q3 2024, an estimated $706K.
  • J. Goldman & Co first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and held it in 7 quarters.
  • J. Goldman & Co's AdvisorShares Pure US Cannabis ETF position peaked at $4.64M in Q1 2024.
  • 170 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2024.

Based on J. Goldman & Co's 13F filing for Q3 2024, filed 14 Nov 2024.